Xi'an International Medical Investment Management
Management criteria checks 4/4
Xi'an International Medical Investment's CEO is Ruixuan Liu, appointed in May 2021, has a tenure of 3.58 years. directly owns 0.048% of the company’s shares, worth CN¥6.31M. The average tenure of the management team and the board of directors is 3.6 years and 3.6 years respectively.
Key information
Ruixuan Liu
Chief executive officer
CN¥600.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.05% |
| Management average tenure | 3.6yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Xi'an International Medical Investment (SZSE:000516) Is Making Moderate Use Of Debt
Nov 21
After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar
Oct 01Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt
Jul 16Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)
Jun 20Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?
Mar 25Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing
Feb 28CEO
Ruixuan Liu (55 yo)
3.6yrs
Tenure
CN¥600,000
Compensation
Mr. Ruixuan Liu has been Vice President and Financial Controller of XKHG since 2005. Mr. Liu served as Vice President of Xi'an International Medical Investment Company Limited. Mr. Liu worked in Xi’an Mins...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 3.6yrs | CN¥600.00k | 0.048% CN¥ 6.3m | |
| Financial Director | 3.6yrs | CN¥450.00k | 0.0071% CN¥ 941.0k | |
| VP & Director | 3.6yrs | CN¥450.00k | 0.015% CN¥ 2.0m | |
| VP & Board Secretary | no data | CN¥450.00k | 0.0069% CN¥ 914.7k | |
| Vice President | no data | CN¥450.00k | 0.0071% CN¥ 941.0k | |
| Vice President | no data | CN¥450.00k | 0.0053% CN¥ 702.5k | |
| Head of Accounting | no data | no data | no data |
3.6yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 000516's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 3.6yrs | CN¥600.00k | 0.048% CN¥ 6.3m | |
| VP & Director | 3.6yrs | CN¥450.00k | 0.015% CN¥ 2.0m | |
| Vice Chairman | 3.6yrs | CN¥500.00k | 1.87% CN¥ 246.3m | |
| Vice-Chairman of the Board of Directors | 3.6yrs | CN¥600.00k | 0.012% CN¥ 1.5m | |
| Independent Director | 3.6yrs | CN¥80.00k | no data | |
| Vice Chairman | 3.6yrs | CN¥450.00k | no data | |
| Member of the Supervisory Board | 3.6yrs | no data | no data | |
| Member of the Supervisory Board | 3.6yrs | no data | no data | |
| Chairman of the Board of Directors | 3.6yrs | CN¥700.00k | 0.021% CN¥ 2.7m | |
| Chairman of the Supervisory Board | 3.6yrs | no data | no data | |
| Independent Director | 3.6yrs | CN¥80.00k | no data | |
| Independent Director | 3.6yrs | CN¥80.00k | no data |
3.6yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 000516's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 06:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Xi'an International Medical Investment Company Limited is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Min Qiu | China Merchants Securities Co. Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |
| Mujun Shen | Citic Securities Co., Ltd. |